BBA
ONCT

Baader Bank Aktiengesellschaft’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-507
Closed -$2.71K – 408
2023
Q3 		$2.71K Buy
+507
New +$3.57K ﹤0.01% 308

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return

Baader Bank Aktiengesellschaft's ONCT Position: Q4 2023 in Review

Baader Bank Aktiengesellschaft sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q4 2023, closing a stake of 507 shares — an estimated $2.71K sold.

Baader Bank Aktiengesellschaft first reported a position in ONCT in Q3 2023 and held it in 1 quarter. The position peaked at $2.71K in Q3 2023. 38 funds tracked by Wall St. Rank hold ONCT as of Q4 2023.

  • Baader Bank Aktiengesellschaft reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 507 Oncternal Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $2.71K.
  • Baader Bank Aktiengesellschaft first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's Oncternal Therapeutics, Inc. Common Stock position peaked at $2.71K in Q3 2023.
  • 38 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2023, filed 8 Feb 2024.